vahl at the weight ratio of 2:3:3:2:3)], a traditional Chinese prescription used for managing summer influenza in China, has been demonstrated to integrate antiviral therapy and immune modulation effects by lowering the expression of Interferon-γ (IFN-γ) and Signal transducer and activator of transcription-1 (STAT1), resulting to reduced inflammation hence harboring key therapeutic benefits against summer influenza (Li et al., 2018). The gene discussed is STAT1; the disease is influenza.